Summary
The concentration of cardiac glycosides to produce positive inotropic effects in the rat heart is markedly higher than that in other species. Such a low digitalis sensitivity of the rat heat is attributed to the low affinity of cardiac Na+, K+-ATPase for digitalis in this species. In the present study the biochemical cause which is responsible for the formation of the unstable complex between the glycosides and Na+, K+-ATPase or positive inotropic, receptor in the rat heart was examined using Na+, K+-ATPase preparations obtained from rat hearts, guinea-pig hearts and rat brains as well as isolated, electrically stimulated atrial preparations obtained from these animals. Monensin, which alters transmembrane Na+ movements without interacting with the cardiotonic sites on Na+, K+-ATPase, had equivalent potencies in guinea-pig and rat hearts. Cassaine, which lacks a lactone ring but interacts with cardiotonic sites on Na+, K+-ATPase, increased the force of contraction in guinea-pig hearts at low, but in rat hearts only at high, concentrations. AY-22,241 (Actodigin) and prednisolone-3,20-bisguanylhydrazone (PBGH) bind to cardiotonic sites on Na+, K+-ATPase and had a similar spectrum as cassaine in these two species. Actodigin has an altered lactone ring resulting in a marked reduction of the inotropic potency, and PBGH is devoid of this structure. With the latter agent, the rabbit was as insensitive as the rat, although both rabbit and guinea-pig are equally sensitive to digitalis. K+ delayed the development of the positive inotropic action of ouabain with a minimal effect on the plateau response in guinea-pig hearts. In rat hearts, however, K+ markedly lowered the plateau response without affecting the time course of the response. These results indicate that the low sensitivity of the rat heart to digitalis is due to a difference in the glycoside binding sites on Na+, K+-ATPase; but the difference cannot be explained by the lack of a lactone ring complementary binding sites. The difference seems to result from the absence of lipid barrier which regulates the rate of release of cardiac glycosides from their binding sites on Na+, K+-ATPase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akera, T.: Quantitative aspects of the interaction between ouabain and (Na++K+)-activated ATPase in vitro. Biochim. Biophys. Acta 249, 53–62 (1971)
Akera, T.: Membrane adenosinetriphosphatase: A digitalis receptor? Science 198, 569–574 (1977)
Akera, T., Hook, J. B., Tobin, T., Brody, T. M.: Cardiac glycoside sensitivity of (Na++K+)-activated ATPase in new-born rats. Res. Comm. Chem. Pathol. Pharmacol. 4, 699–706 (1972)
Akera, T., Tobin, T., Gatti, A., Shieh, I.-S., Brody, T. M.: Effect of potassium on the conformational state of the complex of ouabain with sodium- and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 10, 509–518 (1974)
Akera, T., Temma, K., Wiest, S. A., Brody, T. M.: Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+, K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity. Naunyn-Schmiedeberg's Arch. Pharmacol. 304, 157–165 (1978)
Akera, T., Wiest, S. A., Brody, T. M.: Differential effect of potassium on the action of digoxin and digoxigenin in guine-pig heart. Eur. J. Pharmacol. (1979, in press)
Allen, J. C., Schwartz, A.: A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides. J. Pharmacol. Exp. Ther. 168, 42–46 (1969)
Blesa, E. S., Langer, G. A., Brady, A. J., Serena, S. D.: Potassium exchange in rat ventricular myocardium: Its relation to rate of stimulation. Am. J. Physiol. 219, 747–754 (1970)
Bonting, S. L., Simon, K. A., Hawkins, N. M.: Studies on sodium-potassium activated adenosine triphosphatase. Arch. Biochem. Biophys. 95, 416–423 (1961)
Chen, K. K., Henderson, F. G., Anderson, R. C.: Comparison of forty-two cardiac glycosides and aglycones. J. Pharmacol. Exp. Ther. 103, 420–430 (1951)
Choi, Y. R., Akera, T.: Kinetic studies on the interaction between ouabain and (Na++K+)-ATPase. Biochim. Biophys. Acta 481, 648–659 (1977)
Dransfeld, H., Galetke, E., Greeff, K.: Die Wirkung des Prednisolonbisguanylhydrazones auf die Na+,K+-aktivierte Membran-ATPase des Herz- und Skeletmuskels. Arch. Int. Pharmacodyn. 166, 342–349 (1967)
Ehmer, A., Jahr, K., Kuschinsky, G., Lüllmann, H., Reuter, H., Woller, U.: Über die Herzglykosid-artige Wirkung von Progesteronbisguanylhydrazon (Progesteronbiguazon). Naunyn-Schmiedebergs Arch. Exp. Path. Pharmakol. 248, 521–539 (1964)
Erdmann, E., Schoner, W.: Ouabain-receptor interactions in (Na+,K+)-ATPase preparations. IV. The stoichiometric relationships between inhibitory action of ouabain upon ATP hydrolysis by Na,K-ATPase and the binding of ouabain to isolated membrane preparations. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 335–356 (1974)
Gliklich, J. I., Gaffney, R., Rosen, M. R., Hoffman, B. F.: Effects of AY-22,241 (Actodigin) on electrical and mechanical activity of cardiac tissues. Eur. J. Pharmacol. 32, 1–9 (1975)
Haberland, G.: Chemische Struktur und biologische Wirkung von Digitalisstoffen. In: Probleme der klinischen Prüfung herzwirksamer Glykoside. pp. 1–11. Darmstadt: Dr. Dietrich Steinkopff 1973
Haustein, K.-O., Hauptmann, J.: Studies on cardioactive steroids. Pharmacology 11, 129–138 (1974)
Howard, L. L., Brunschwig, J. P., Pressman, B. C.: Affect of the ionophore monensin on cultured beating heart cells. Pharmacologist 18, 122 (1976)
Klaassen, C. D.: Stimulation of the development of the hepatic excretory mechanism for ouabain in newborn rats with microsomal enzyme inducers. J. Pharmacol. Exp. Ther. 191, 212–218 (1974)
Ku, D. D., Akera, T., Tobin, T., Brody, T. M.: Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na+,K+-ATPase and contractile force. J. Pharmacol. Exp. Ther. 197, 458–469 (1976)
Langer, G. A.: The role of sodium ion in the regulation of myocardial contractility. J. Mol. Cell Cardiol. 1, 203–207 (1970)
Levy, J. V.: Isolated atrial preparations. In: Methods in Pharmacology, Vol. 1, pp. 77–104. New York: Appleton-Century-Crofts 1971
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Naidoo, B. K., Witty, T. R., Remers, W. A., Besch, H. R., Jr.: Cardiotonic steroids: Importance of 14β-hydroxy group in digitoxigenin. J. Pharm. Sci. 63, 1391–1394 (1974)
Portius, H. J., Repke, K.: Versuch einer Analyse der Beziehungen zwischen chemischer Struktur und Digitalis-ähnlicher Wirksamkeit auf der Rezeptorebene. Arzneim.-Forsch. 14, 1073–1077 (1964)
Repke, K., Est, M., Portius, H. J.: Über die Ursache der Speciesunterschiede in der Digitalisempfindlichkeit. Biochem. Pharmacol. 14, 1785–1802 (1965)
Skou, J. C.: The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta 23, 394–401 (1957)
Tobin, T., Brody, T. M.: Rates of dissociation of enzyme-ouabain complexes and K0.5 values (Na++K+) adenosine triphosphatase from different species. Biochem. Pharmacol. 21, 1553–1560 (1972)
Tobin, T., Henderson, R., Sen, A. K.: Species and tissue differences in the rate of dissociation of ouabain from (Na++K+)-ATPase. Biochim. Biophys. Acta 274, 551–555 (1972)
Tobin, T., Akera, T., Brody, S. L., Ku, D., Brody, T. M.: Cassaine: Mechanism of inhibition of Na++K+-ATPase and relationship of this inhibition to cardiotonic actions. Eur. J. Pharmacol. 32, 133–145 (1975)
Wallick, E. T., Dowd, F., Allen, J. C., Schwartz, A.: The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+,K+-adenosine triphosphatase interaction. J. Pharmacol. Exp. Ther. 189, 434–444 (1974)
Wilson, W. E., Sivitz, W. I., Hanna, L. T.: Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model. Mol. Pharmacol. 6, 449–459 (1970)
Winergrad, S., Shanes, A. M.: Calcium flux and contractility in guinea pig atria. J. Gen. Physiol. 45, 371–394 (1962)
Yamamoto, S.: Prednisolone-3,20-bisguanylhydrazone: The mode of interaction with rat brain sodium and potassium-activated adenosine triphosphatase. Eur. J. Pharmacol. 50, 409–418 (1978)
Yamamoto, S., Akera, T., Brody, T. M.: Prednisolone-3,20-bisguanylhydrazone: Na+,K+-ATPase inhibition and positive inotropic action. Eur. J. Pharmacol. 49, 121–132 (1978)
Yoda, A., Yoda, S.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. III. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium and adenosine triphosphate. Mol. Pharmacol. 10, 494–500 (1974)
Yoda, A., Yoda, S.: Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium-and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate. Mol. Pharmacol. 13, 352–361 (1977)
Author information
Authors and Affiliations
Additional information
This work was supported by U.S. Public Health Service grant, HL-16052 and by the Michigan Heart Association
Rights and permissions
About this article
Cite this article
Akera, T., Yamamoto, S., Chubb, J. et al. Biochemical basis for the low sensitivity of the rat heart to digitalis. Naunyn-Schmiedeberg's Arch. Pharmacol. 308, 81–88 (1979). https://doi.org/10.1007/BF00499048
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499048